Glossary

I am a patient	Home Links Site Map Contact Us
Healthcare Professional Section > Glossary
What is PAH? How is PAH diagnosed? How is PAH treated? What is PAH in Systemic Sclerosis (SSc)? Assessing the severity of PAH Glossary Further information?	Glossary A B C D E F G H I J K L M N O P Q R S T U V W X Y Z A Anticoagulants Associated pulmonary arterial hypertension (APAH) Autoantibody C Calcium channel blockers Collagen Congenital heart disease Connective tissue disease (CTD) CT scan (Computerised Tomography) Cyanosis D Diffuse cutaneous systemic sclerosis (dcSSc) Diuretics Dyspnoea E Echocardiography or Doppler echocardiogram EEisenmenger’s Syndrome / Physiology Electrocardiogram (ECG) Endothelin (ET) Endothelin receptor antagonist (ERA) Endothelin receptors Endothelium Extracellular matrix F Familial pulmonary arterial hypertension (FPAH) Fibroblasts Fibrosis H Human immunodeficiency virus (HIV) Hypertrophy I Idiopathic pulmonary arterial hypertension (IPAH) Inflammation Interstitial lung disease Ischaemia L Limited cutaneous systemic sclerosis (LcSSc) N New York Heart Association (NYHA) Nitric oxide (NO) P Portal hypertension Primary pulmonary hypertension (PPH) Prostacyclin Prostanoids Pulmonary arterial hypertension (PAH) Pulmonary artery Pulmonary fibrosis R Remodelling Right heart catheterisation RRaynaud’s phenomenon S Scleroderma or Systemic Sclerosis Sleep Apnoea Syncope (fainting) Systemic lupus erythematosus (SLE) or Lupus T Telangiectases V Vascular remodelling Vasculopathy Vasoconstriction Vasodilation W WHO Functional Class

Home | Legal | Contact Us | Printer Friendly